Danaher expects about $350M in tariff costs; Alumis, Acelyrin adjust deal terms

Plus, news about Invivyd: Danaher’s tariffs hit: The life sciences company currently expects the costs of tariffs to be “something like $350 million” in 2025, according to CEO Rainer Blair on Tuesday’s earnings call. Danaher ...

Apr 22, 2025 - 15:48
 0
Danaher expects about $350M in tariff costs; Alumis, Acelyrin adjust deal terms
Plus, news about Invivyd: Danaher’s tariffs hit: The life sciences company currently expects the costs of tariffs to be “something like $350 million” in 2025, according to CEO Rainer Blair on Tuesday’s earnings call. Danaher ...